Lotus Eye Hospital & Institute (BOM:532998) Other Financing: ₹0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532998 Lotus Eye Hospital & Institute Ltd BOM:532998
67 GF Score
Price ₹120.05
GF Value ₹92.27
Valuation Modestly Overvalued
View Full Analysis

What is Lotus Eye Hospital & Institute Other Financing?

Lotus Eye Hospital & Institute BOM:532998 +0.50% 67 Other Financing is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:532998 with a GF Score™ of 67/100 and a GF Value™ of ₹92.27 (Modestly Overvalued).

Lotus Eye Hospital & Institute's Other Financing for the three months ended in Mar. 2026 was ₹0.0 Mil.

Lotus Eye Hospital & Institute's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Lotus Eye Hospital & Institute Other Financing Historical Data

* Premium members only.

The historical data trend for Lotus Eye Hospital & Institute's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Eye Hospital & Institute Other Financing Chart

Lotus Eye Hospital & Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.28 -0.98 -0.97 -3.55 -8.13

Lotus Eye Hospital & Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:532998
67GF Score
Lotus Eye Hospital & Institute Ltd BOM:532998
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lotus Eye Hospital & Institute Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ₹0.0 Mil mean?
Lotus Eye Hospital & Institute (BOM:532998) has a Other Financing of ₹0.0 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Lotus Eye Hospital & Institute and its competitors.
Is Lotus Eye Hospital & Institute's Other Financing too high?
Lotus Eye Hospital & Institute's current Other Financing is ₹0.0 Mil. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's Other Financing compare to HCA and THC?
Lotus Eye Hospital & Institute's Other Financing of ₹0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Lotus Eye Hospital & Institute and its competitors. Lotus Eye Hospital & Institute's current Other Financing is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹92.27, compared to a current price of ₹120.05 — trading 30.1% above its estimated fair value. The current Other Financing is ₹0.0 Mil. Lotus Eye Hospital & Institute's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current Other Financing is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?

Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued. The current stock price of ₹120.05 is trading 30.1% above its estimated GF Value™ of ₹92.27. GuruFocus considers Lotus Eye Hospital & Institute to be Modestly Overvalued.

Key valuation signals for BOM:532998:

  • Other Financing: ₹0.0 Mil
  • GF Value™: ₹92.27 vs. price of ₹120.05 (30.1% above fair value)
  • GF Score™: 67/100

No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lotus Eye Hospital & Institute Business Description

Other Exchanges LOTUSEYE:India
Address SF No. 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, TN, IND, 641 014
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
67GF Score

Get the complete analysis for BOM:532998

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹120.05
Price
₹92.27
GF Value